TradingMula

Esperion Therapeutics Ready To Bounce Back

Long
TradingMula Updated   
NASDAQ:ESPR   Esperion Therapeutics, Inc.
Risk $1 for $9 to target $40
Trade closed: target reached:
target hit

Like, comment or follow if you like my ideas!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.